Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 4;14(6):e0217805.
doi: 10.1371/journal.pone.0217805. eCollection 2019.

Progression of subclinical choroidal neovascularization in age-related macular degeneration

Affiliations

Progression of subclinical choroidal neovascularization in age-related macular degeneration

Michael J Heiferman et al. PLoS One. .

Abstract

Purpose: To use optical coherence tomography angiography (OCTA) to study longitudinal subclinical choroidal neovascularization (CNV) changes and their correlation with progression to exudation in age-related macular degeneration (AMD).

Methods: This study included a total of 34 patients with unilateral neovascular AMD who were evaluated prospectively using OCTA to detect subclinical CNV in their fellow eye. Eyes with baseline subclinical CNV were followed with serial OCTA for a minimum of one year (15.2±3.27 months) to monitor the development of exudation.

Results: Of the 34 fellow eyes studied, five were found to have baseline subclinical CNV. One of the five cases of baseline subclinical CNV converted to exudative AMD during the follow up period. The average surface area of baseline subclinical CNV on OCTA was 0.131±0.096 mm2 which progressed to 0.136±0.104 mm2 at the final follow up (P = 0.539). Geographic atrophy grew at a rate of 0.82±1.20mm2/year in four eyes without subclinical CNV and 0.02mm2/year in one eye with subclinical CNV.

Conclusion and importance: The rate of conversion to exudative AMD in eyes with subclinical CNV of 20% in our study is similar to previous reports and suggests the importance of vigilance in these eyes. The lower growth rate of geographic atrophy may suggest a protective effect of subclinical CNV that deserves further study.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Example of subclinical CNV analysis.
A: En face OCTA slab of subclinical CNV. B: Flow area selection tool used in the AngioVue software. C: OCTA B-scan with flow marked in red. The horizontal green line seen in panel A marks the section of OCTA B-scan image. D: The same OCTA B-scan segmented 72 microns below (green line) the inner plexiform layer to Bruch’s membrane (red line).
Fig 2
Fig 2. Case of subclinical CNV that converted to exudative AMD.
Fig 3
Fig 3. Case of subclinical CNV that remained relatively stable in surface area and flow area.

References

    1. Congdon N, O'Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477–85. 10.1001/archopht.122.4.477 - DOI - PubMed
    1. Chew EY, Clemons TE, Agron E, Sperduto RD, Sangiovanni JP, Davis MD, et al. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36. JAMA Ophthalmol. 2014;132(3):272–7. 10.1001/jamaophthalmol.2013.6636 - DOI - PMC - PubMed
    1. Lamoureux EL, Mitchell P, Rees G, Cheung G, Yeo I, Lee SY, et al. Impact of early and late age-related macular degeneration on vision-specific functioning. Br J Ophthalmol. 2011;95(5):666–70. 10.1136/bjo.2010.185207 - DOI - PubMed
    1. Sarks SH. Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol. 1976;60(5):324–41. 10.1136/bjo.60.5.324 - DOI - PMC - PubMed
    1. Green WR, Key SN 3rd. Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc. 1977;75:180–254. - PMC - PubMed

Publication types